The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations

NCT02855047 · clinicaltrials.gov ↗
COMPLETED
Status
513
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Centre Hospitalier Universitaire de Nīmes